close

Mergers and Acquisitions

1 2 3 4 5 30
Number of results: 582
Date Acquired company Acquiring company Amount Related
2016-12-15 TangenX Technology (USA - MA) Repligen (USA - MA) €37 million ($ 39 million)

Technology - Services

2016-12-10 Encore Vision (USA - TX) Novartis (Switzerland) undisclosed Ophtalmological diseases
2016-12-07 Lonza's peptides business and operations in Brain-l'Alleud PolyPeptide Laboratories (USA - CA) undisclosed

Technology - Services

2016-12-02 Acetylon Pharmaceuticals (USA - MA) Celgene (USA - NJ) undisclosed

Cancer - Oncology

Autoimmune diseases

2016-11-30 G7 Therapeutics (Switzerland) Heptares Therapeutics (UK), a wholly-owned subsidiary of Sosei Group (Japan) CHF 12 million

Technology - Services

2016-11-29 Aegerion Pharmaceuticals (USA - MA) QLT (Canada), now Novelion Therapeutics (Canada)
2016-11-22 Chase Pharmaceuticals (USA - MD) Allergan (Ireland) $125 million and additional milestone payments
2016-11-21 Atopix Therapeutics (UK) Chiesi Farmaceutici (Italy) €75 million

Allergic diseases - Respiratory diseases

2016-11-21 Selexys Pharmaceuticals (USA - OK) Novartis (Switzerland) up to $665 million in upfront, acquisition and milestone payments Hematological diseases - Rare diseases
2016-11-08 AccelLAB (Canada) CiToxLAB (France) undisclosed Technology - Services - Medical devices
2016-11-01 BioPhausia (Sweden) Karo Pharma (Sweden) SEK 908 million (€ 91.92 million)
2016-11-01 Kolltan Pharmaceuticals (USA - CT) Celldex Therapeutics (USA - NJ) $ 235 million (€ 214.1 million)

Cancer - Oncology

2016-10-31 Telesta Therapeutics (Canada) Prometic Life Sciences (Canada)

Cancer - Oncology

Immunological diseases

2016-10-28 Ganymed Pharmaceuticals (Germany) Astellas Pharma (Japan) up to € 1.28 billion

Cancer - Oncology

2016-10-27 Rhythm Health, now Motus Therapeutics (USA - MA) Actavis, now Allergan (Ireland) $200 million and contingent payment upon first commercial sale of relamorelin

Gastrointestinal diseases

2016-10-13 animal health vaccines and pharmaceuticals from Merial portfolio Ceva Santé Animale (France) undisclosed

Veterinary medicine

2016-10-12 Immunetics (USA - MA) Oxford Immunotec (UK) up to $ 12 million
2016-10-07 PharmaCore (USA - NC) Cambrex (USA - NJ) $25 million Technology - Services
2016-10-03 Allergan's Anda (Ireland) Teva Pharmaceutical Industries (Israel) $500 million

Generics

Distribution

2016-09-28 4SC's immunology portfolio Immunic (Germany) undisclosed

Autoimmune diseases

Immunological diseases